Humanised antibodies to Toll-like Re- ceptor 2 and uses thereof

Details for Australian Patent Application No. 2010270241 (hide)

Owner Opsona Therapeutics Limited

Inventors Dellacasagrande, Jerome

Agent Wrays

Pub. Number AU-A-2010270241

PCT Pub. Number WO2011/003925

Priority 2009/0514 06.07.09 IE; 61/270,239 06.07.09 US

Filing date 6 July 2010

Wipo publication date 13 January 2011

International Classifications

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/13 (2006.01) Mutation or genetic engineering - Immunoglobulins

Event Publications

2 February 2012 PCT application entered the National Phase

  PCT publication WO2011/003925 Priority application(s): WO2011/003925

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010270243-Roadway structure having improved adhesive properties

2010270227-Method for predicting efficacy of drugs in a patient